Literature DB >> 17239976

Stress testing response in women heterozygous for familial hypercholesterolemia.

Genovefa D Kolovou, Dimitris S Damaskos, Katherine K Anagnostopoulou, Klelia D Salpea, Athanasios Dritsas, Vasiliki Giannakopoulou, Ioannis K Vasiliadis, Dennis V Cokkinos.   

Abstract

We evaluated 62 exercise treadmill tests (ETTs) in equal numbers of heterozygous for familial hypercholesterolemia (hFH) and healthy (HLY) women, matched for age, baseline systolic and diastolic blood pressure (BP) and baseline heart rate (HR), using the Bruce protocol. Both groups had similar rate pressure product (RPP) and workload in metabolic equivalents (METs) (27,563+/-3124 vs. 29,090+/-4077, p=0.103 and 11.2+/-1.7 vs. 11.5+/-1.8, p=0.473, respectively). Women with hFH had lower delta (difference of peak to baseline) and peak exercise systolic and diastolic BP (systolic: 48+/-12 vs. 58+/-17 mmHg, p=0.010 and 167+/-19 vs. 177+/-17 mmHg, p=0.042, respectively; diastolic: 11+/-7 vs. 15+/-7 mmHg, p=0.028 and 85+/-7 vs. 91+/-7 mmHg, p<0.001, respectively). Furthermore, women with hFH had higher delta percentage (%) of HR, compared to HLY; (106+/-25 vs. 95+/-20, p=0.047). In conclusion, hFH women possibly have an inadequate rise in systolic BP during ETT. Diastolic BP increased more in the HLY than in the hFH group, but still remained within normal limits. These findings may reflect preclinical changes of atherosclerosis in hFH women, however further research should be undertaken.

Entities:  

Mesh:

Year:  2007        PMID: 17239976     DOI: 10.1016/j.ijcard.2006.11.046

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Myocardial strain impairment, heterozygous familial hypercholesterolemia and systemic arterial hypertension: Is there a link?

Authors:  Antonio Vitarelli
Journal:  Int J Cardiol Hypertens       Date:  2021-05-11

2.  Reduced global longitudinal strain at rest and inadequate blood pressure response during exercise treadmill testing in male heterozygous familial hypercholesterolemia patients.

Authors:  Vasiliki Vartela; Iakovos Armenis; Dimitra Leivadarou; Konstantinos Toutouzas; Konstantinos Makrilakis; George D Athanassopoulos; George Karatasakis; Genovefa Kolovou; Sophia Mavrogeni; Despina Perrea
Journal:  Int J Cardiol Hypertens       Date:  2021-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.